Viewing Study NCT02797951

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:48 PM
Ignite Modification Date: 2026-02-22 @ 4:14 PM
Study NCT ID: NCT02797951
Status: COMPLETED
Last Update Posted: 2022-02-10
First Post: 2016-06-09
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
Sponsor: Eli Lilly and Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Episodic Cluster Headache View
None Chronic Cluster Headache View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cluster headache View
None headache View
None brain diseases View
None central nervous system diseases View
None headache disorders View
None headache disorders, primary View
None nervous system diseases View
None neurologic manifestations View
None pain View
None trigeminal autonomic cephalalgias View